From: Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women
State prevalences (%) n=330
Transition probabilities
Before pregnancy
During pregnancy
→ ACT/QNN
→ Others
→ SP
ACT/QNN →
74.5
41.9
0.451
0.085
0.463
Others →
12.1
7.9
0.425
0.025
0.550
SP →
13.3
51.2
0.159
0.091
0.750